IX Biopharma Company Announcements (42C)

SGX Google Yahoo News TradingView

IX BIOPHARMA LTD. (42C) SGD 0.024 +0.00% +0.00

Portfolio Watchlist

All Financial Buy Back Insider Trading

2016-08-10

General Announcement::iX Biopharma is Developing its Next Drug in Pain Management

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-21

REPL::Rights::Voluntary

2016-07-18

General Announcement::Results of the Rights Issue

2016-07-04

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-01

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-01

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-01

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-01

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-06-30

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-06-27

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2016-06-24

General Announcement::REPL::Rights::Voluntary

2016-06-24

REPL::Rights::Voluntary

2016-06-15

REPL::Rights::Voluntary

2016-06-14

REPL::Rights::Voluntary

2016-06-09

General Announcement::iX Biopharma Secures South Korea Patent for Waferix

2016-06-02

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2016-05-27

Rights::Voluntary

2016-05-26

Asset Acquisitions and Disposals::Arrow Property Trust and Kaizen Manufacturing Pty Ltd Become Wholly-Owned Subsidiaries

2016-05-11

Financial Statements and Related Announcement::Third Quarter Results

2016-04-25

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities

2016-04-21

REPL::Placements::COMPLETION OF THE PROPOSED PLACEMENT

2016-04-20

REPL::Placements::RECEIPT OF LISTING AND QUOTATION NOTICE

2016-04-14

Placements::PROPOSED PLACEMENT OF 14,358,000 NEW ORDINARY SHARES IN THE CAPITAL OF IX BIOPHARMA LTD.

2016-04-12

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2016-04-07

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2016-03-21

Change - Announcement of Cessation::Cessation of Chief Financial Officer

2016-03-21

Change - Announcement of Appointment::Appointment of Chief Financial Officer

2016-03-21

General Announcement::Change of Chief Financial Officer

2016-03-07

General Announcement::iX Biopharma Reports Positive Results From Multi-Dose Wafermine Clinical Trial

2016-02-04

Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results

2016-01-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2016-01-18

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2015-11-30

General Announcement::iX Biopharma Secures Indonesia Patent for WaferiX Technology

2015-11-25

General Announcement::iX Biopharma Announces Success of Pilot Bioavailability Study for PheoniX

2015-11-11

Financial Statements and Related Announcement::First Quarter Results

2015-10-29

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2015-10-23

REPL::Annual General Meeting::Voluntary

2015-10-06

Annual Reports and Related Documents::

2015-10-06

Annual General Meeting::Voluntary

2015-10-05

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2015-09-28

General Announcement::iX Biopharma Secures Japanese Patent for WaferiX Technology

2015-09-25

Change - Announcement of Appointment::Appointment of General Manager

2015-09-25

Change - Announcement of Appointment::Appointment of Chief Scientist

2015-09-17

General Announcement::iX Biopharma Reports Success of Single-Dose Wafermine Clinical Trials

2015-09-14

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

© 2024 Dividends.sg / More Countries

© Owned by Little White Pte. Ltd.